Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Liu, Ran ^a   Yang, Miao ^a   Meng, Yanli ^b   Liao, Juan ^a   Sheng, Jingyi ^a   Pu, Yuepu ^a   Yin, Lihong ^a   Kim, Sun Jung ^c  

^a SOUTHEAST UNIVERSITY   (China)

^b North China Petroleum Bureau General Hospital   (China)

^c Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; GELATINASE B; LIVER RECEPTOR HOMOLOG 1; MICRORNA; MICRORNA 193 5P; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CCNE1 PROTEIN, HUMAN; CELL RECEPTOR; MIRN139 MICRORNA, HUMAN; NR5A2 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE CONTROL; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; WESTERN BLOTTING; AGED; CELL CYCLE CHECKPOINT; CELL MOTION; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN E; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICRORNAS; MIDDLE AGED; ONCOGENE PROTEINS; PROGNOSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84885777831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077068     Document Type: Article

References (30)

1. Carrington JC, Ambros V, (2003) Role of microRNAs in plant and animal development. Science 301: 336-338.
2. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
3. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
5. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
6. Bader AG, Brown D, Stoudemire J, Lammers P, (2011) Developing therapeutic microRNAs for cancer. Gene Ther 18: 1121-1126.
7. Dalmay T, (2008) MicroRNAs and cancer. J Intern Med 263: 366-375.
8. Kwak PB, Iwasaki S, Tomari Y, (2010) The microRNA pathway and cancer. Cancer Sci 101: 2309-2315.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
10. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN, (2008) Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334.
11. Enzinger PC, Mayer RJ, (2003) Esophageal cancer. N Engl J Med 349: 2241-2252.
12. Matsushima K, Isomoto H, Kohno S, Nakao K, (2010) MicroRNAs and esophageal squamous cell carcinoma. Digestion 82: 138-144.
13. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, et al. (2010) miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814.
14. Guo H, Hu X, Ge S, Qian G, Zhang J, (2012) Regulation of RAP1B by miR-139 Suppresses Human Colorectal Carcinoma Cell Proliferation. Int J Biochem Cell Biol 44: 1465-1472.
15. Hasseine LK, Hinault C, Lebrun P, Gautier N, Paul-Bellon R, et al. (2009) miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes. Biochem Biophys Res Commun 390: 1278-1282.
16. Shen K, Liang Q, Xu K, Cui D, Jiang L, et al. (2012) MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 84: 320-330.
17. Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, et al. (2004) Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15: 499-509.
18. Chand AL, Wijayakumara DD, Knower KC, Herridge KA, Howard TL, et al. (2012) The orphan nuclear receptor LRH-1 and ERalpha activate GREB1 expression to induce breast cancer cell proliferation. PLoS One 7: e31593.
19. Chand AL, Herridge KA, Thompson EW, Clyne CD, (2010) The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer 17: 965-975.
20. Benod C, Vinogradova MV, Jouravel N, Kim GE, Fletterick RJ, et al. (2011) Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc Natl Acad Sci U S A 108: 16927-16931.
21. Wang SL, Zheng DZ, Lan FH, Deng XJ, Zeng J, et al. (2008) Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis. Mol Cell Biochem 308: 93-100.
22. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, et al. (2011) The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818.
23. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, et al. (2011) The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140: 322-331.
24. Schoonjans K, Dubuquoy L, Mebis J, Fayard E, Wendling O, et al. (2005) Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci U S A 102: 2058-2062.
25. Wagner RT, Xu X, Yi F, Merrill BJ, Cooney AJ, (2010) Canonical Wnt/beta-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells 28: 1794-1804.
26. Wang S, Lan F, Huang L, Dong L, Zhu Z, et al. (2005) Suppression of hLRH-1 mediated by a DNA vector-based RNA interference results in cell cycle arrest and induction of apoptosis in hepatocellular carcinoma cell BEL-7402. Biochem Biophys Res Commun 333: 917-924.
27. Baquie M, St-Onge L, Kerr-Conte J, Cobo-Vuilleumier N, Lorenzo PI, et al. (2011) The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis. Hum Mol Genet 20: 2823-2833.
28. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
29. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.
30. Liu R, Liao J, Yang M, Sheng J, Yang H, et al. (2012) The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One 7: e33987.